Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Depression × Drug Delivery Systems × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5 Glioblastoma 4 Urinary Bladder Neoplasms 2 Glioma 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Astrocytoma 2 Uterine Cervical Neoplasms 1 Thyroid Nodule 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Pleural Neoplasms 1 Pancreatic Neoplasms 1 Pancreatic Cyst 1 Oropharyngeal Neoplasms 1 Mouth Neoplasms 1 Medication Adherence 1 Margins of Excision 1 Lymphedema 1 Lung Neoplasms 1 Liver Neoplasms 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Early-stage Peripheral Non-small Cell Lung Cancer 1 Disease 1 Depression 1 Carcinoma, Renal Cell 1

Interventions

Therapeutics 21 Psychiatric Rehabilitation 17 Cognitive Behavioral Therapy 10 Early Intervention, Educational 9 Psilocybin 8 Ketamine 8 Yoga 6 Saline Solution 6 Methods 6 Counseling 6 Surveys and Questionnaires 5 Mindfulness-Based Cognitive Therapy 5 Methylphenidate 5 Esketamine 5 Behavior Therapy 5 Acupuncture Therapy 5 Psychosocial Intervention 4 Mindfulness 4 Interviews as Topic 4 Exercise Therapy 4 Escitalopram 4 Educational Status 4 Control Groups 4 Caregivers 4 Psychotherapy 3 Palliative Care 3 Niacin 3 Melatonin 3 Meditation 3 Hypnosis 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01701284 2023-11-18

rTMSinCP

Northwestern University

Phase NA Completed

Anxiety Disorders, Depression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡